Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Connecting the Dots: An RCT Integrating Standardized ASD Screening, High-Quality Treatment, and Long-Term Outcomes

NCT03333629 is registered in ClinicalTrials.gov with Drexel University as lead sponsor.

NCT NCT03333629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03333629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Connecting the Dots: An RCT Integrating Standardized ASD Screening, High-Quality Treatment, and Long-Term Outcomes
Lead sponsor
Drexel University
Phase
Phase 4
Overall status
Completed
Start date
November 29, 2017
Completion date
June 30, 2024
Enrollment
2,087 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder